Bone Marrow Transplant at Artemis Hospital in Gurgaon, India

Bone marrow transplant appointments, second opinions, donor matching assessments, and treatment planning at Artemis Hospital in Gurgaon, India are coordinated through the International Patient Care team, available 24/7.

• WhatsApp: +1 718 550 0880
• Telephone: +1 718 550 0880
• Email: [email protected]

The team arranges online video consultations with BMT specialists, review of HLA typing results and diagnosis reports, written cost estimates, airport transfers, and full treatment coordination before and after travel.

The length of stay at Artemis depends on your transplant type and how quickly engraftment occurs.

• Autologous BMT: hospital stay of approximately 3-4 weeks; most patients can travel home within 5-6 weeks
• Allogeneic or haploidentical BMT: hospital stay of 4-6 weeks; a stay of 8-10 weeks in total near the hospital is strongly recommended
• Paediatric BMT: inpatient stay varies between 4-8 weeks depending on the child's recovery; the 100-day monitoring window is a critical period
• Cord blood transplant: recovery is generally slower; a longer total stay of 10-12 weeks may be needed before flying is safe

Before you travel, the international patient team provides a full treatment itinerary with planned admission, transplant, engraftment monitoring, and an estimated departure date.

Bone marrow transplant at Artemis Hospital costs significantly less than equivalent procedures in Western countries, with autologous BMT ranging from $18,000 to $25,000 and allogeneic BMT from $32,000 to $45,000. 

The same procedures in the United States start from $90,000 and can exceed $300,000 for allogeneic transplants with extended inpatient stays. 

A written cost estimate covering conditioning, the transplant procedure, inpatient monitoring, and post-discharge medication is provided before you travel, with no financial commitment required to receive it.

Artemis Hospital is awarded Best Bone Marrow Transplant Centre in North India and holds JCI and NABH accreditation. 

The BMT programme has completed 500+ transplants with an overall success rate of approximately 85%, and the team includes 17 specialist doctors among them British and USA board-certified haematologists. 

Dr Lalit Kumar, Chairperson of Oncology and BMT, is a recipient of the Padma Shri,  India's fourth-highest civilian honour, for his contributions to medicine, and was formerly Professor and Head of Medical Oncology at AIIMS New Delhi, one of India's most prestigious institutions.

Post-transplant follow-up at Artemis is structured to continue remotely once you return home. 

Your treating BMT specialist is available for scheduled video consultations, and the international patient coordinator remains your direct point of contact for any concerns about infection, medication, graft function, or early signs of GVHD. 

Secure digital access to your transplant records, blood results, and discharge documentation is available through the patient portal, allowing your local haematologist to continue monitoring with a complete clinical picture. 

The first 100 days after transplant are treated as an active care period regardless of where you are.

Not having a matched sibling does not prevent treatment at Artemis. Only 25-30% of patients have a fully matched sibling donor, so the BMT programme at Artemis is specifically built to cover alternative donor routes.

• Haploidentical transplant using a half-matched parent or sibling
• Cord blood transplant, which tolerates greater HLA mismatch
• Matched unrelated donor transplant via national or international registries
• Paired or sequential approaches for complex donor situations

HLA typing of your available family members can be reviewed before you travel to confirm which donor option fits your case.